Literature DB >> 32415401

Improving the Safety of Major Resection for Hepatobiliary Malignancy: Portal Vein Embolization and Recent Innovations in Liver Regeneration Strategies.

David C Madoff1, Bruno C Odisio2, Erik Schadde3,4,5, Ron C Gaba6, Roelof J Bennink7, Thomas M van Gulik8, Boris Guiu9.   

Abstract

PURPOSE OF REVIEW: For three decades, portal vein embolization (PVE) has been the "gold-standard" strategy to hypertrophy the anticipated future liver remnant (FLR) in advance of major hepatectomy. During this time, CT volumetry was the most common method to preoperatively assess FLR quality and function and used to determine which patients are appropriate surgical candidates. This review provides the most up-to-date methods for preoperatively assessing the anticipated FLR and summarizes data from the currently available strategies used to induce FLR hypertrophy before surgery for hepatobiliary malignancy. RECENT
FINDINGS: Functional and physiological imaging is increasingly replacing standard CT volumetry as the method of choice for preoperative FLR assessment. PVE, associating liver partition and portal vein ligation, radiation lobectomy, and liver venous deprivation are all currently available techniques to hypertrophy the FLR. Each strategy has pros and cons based on tumor type, extent of resection, presence or absence of underlying liver disease, age, performance status, complication rates, and other factors. Numerous strategies can lead to FLR hypertrophy and improve the safety of major hepatectomy. Which is best has yet to be determined.

Entities:  

Keywords:  ALPPS; Future liver remnant; Hepatic regeneration; Liver venous deprivation; Portal vein embolization; Radiation lobectomy

Year:  2020        PMID: 32415401     DOI: 10.1007/s11912-020-00922-x

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  9 in total

1.  Predictors of Liver Failure in Non-Cirrhotic Patients Undergoing Hepatectomy.

Authors:  Gabriel Orozco; Meera Gupta; Diego Villagomez; Malay Shah; Francesc Marti; Xiaonan Mei; Alexandre Ancheta; Siddharth Desai; Fady Salama; Karim Benrajab; Daniel Davenport; Roberto Gedaly
Journal:  World J Surg       Date:  2022-10-08       Impact factor: 3.282

2.  Combined simultaneous embolization of the portal vein and hepatic vein (double vein embolization) - a technical note about embolization sequence.

Authors:  Arash Najafi; Erik Schadde; Christoph A Binkert
Journal:  CVIR Endovasc       Date:  2021-05-26

3.  99mTc-mebrofenin hepatobiliary scintigraphy and volume metrics before liver preparation: correlations and discrepancies in non-cirrhotic patients.

Authors:  Boris Guiu; Emmanuel Deshayes; Fabrizio Panaro; Florian Sanglier; Caterina Cusumano; Astrid Herrerro; Olivia Sgarbura; Nicolas Molinari; François Quenet; Christophe Cassinotto
Journal:  Ann Transl Med       Date:  2021-05

4.  MMP2/9 downregulation is responsible for hepatic function recovery in cirrhotic rats following associating liver partition and portal vein ligation for staged hepatectomy.

Authors:  Yugang Qin; Chonghui Li; Xinlan Ge; Qiang Zhang; Xiaojun Wei; Rong Liu
Journal:  Ann Transl Med       Date:  2022-04

5.  To Systematically Evaluate and Analyze the Efficacy and Safety of Transcatheter Arterial Chemoembolization (TACE) in the Treatment of Primary Liver Cancer.

Authors:  Xiao Yang; Tingting Lan; Hui Zhong; Zujian Zhang; Hui Xie; Youwei Li; Wen Huang
Journal:  J Healthc Eng       Date:  2022-03-21       Impact factor: 2.682

Review 6.  Current trends in regenerative liver surgery: Novel clinical strategies and experimental approaches.

Authors:  Jan Heil; Marc Schiesser; Erik Schadde
Journal:  Front Surg       Date:  2022-09-07

7.  Hepatobiliary Scintigraphy and Glass 90Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated Liver.

Authors:  Carole Allimant; Emmanuel Deshayes; Marilyne Kafrouni; Lore Santoro; Delphine de Verbizier; Marjolaine Fourcade; Christophe Cassinotto; Margaux Hermida; Chloé Guillot; Denis Mariano-Goulart; Boris Guiu
Journal:  Diagnostics (Basel)       Date:  2021-05-21

8.  Feasibility and Safety of Delayed Catheter Removal Technique in Percutaneous Trans-Hepatic Portal Vein Embolization.

Authors:  Chengjian He; Naijian Ge; Yefa Yang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 9.  Induction of liver hypertrophy for extended liver surgery and partial liver transplantation: State of the art of parenchyma augmentation-assisted liver surgery.

Authors:  Philip C Müller; Michael Linecker; Elvan O Kirimker; Christian E Oberkofler; Pierre-Alain Clavien; Deniz Balci; Henrik Petrowsky
Journal:  Langenbecks Arch Surg       Date:  2021-03-19       Impact factor: 3.445

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.